ABOUT ORAL LIQUIDS

pentobarbital will lessen the extent or result of ombitasvir/paritaprevir/ritonavir & dasabuvir (DSC) by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Solid CYP3A4 inducers may reduce partiaprevir and ritonavir levels, and as a consequence lessened efficacy of Viekira Pakpentobarbital decreases effects of sufentanil SL by